Evidence map›Paper›PMID 38939213›Full record

ArticleJournal of extracellular biology2022

Large-scale production of extracellular vesicles: Report on the "massivEVs" ISEV workshop.

Lucia Paolini, Marta Monguió-Tortajada, Marta Costa, Fabio Antenucci, Mario Barilani, Marta Clos-Sansalvador, André Cronemberger Andrade, Tom A P Driedonks, Sara Giancaterino, Stephanie M Kronstadt and 24 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of extracellular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Lucia PaoliniDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.ORCID https://orcid.org/0000-0002-4410-5272
Marta Monguió-TortajadaCREC Research Program Health Science Research Institute Germans Trias i Pujol (IGTP) Badalona Spain.ORCID https://orcid.org/0000-0003-2125-0810
Marta CostaiBET Instituto de Biologia Experimental e Tecnológica Oeiras Portugal.
Fabio AntenucciDepartment of Veterinary and Animal Sciences University of Copenhagen Copenhagen Denmark.
Mario BarilaniLaboratory of Regenerative Medicine ‒ Cell Factory Department of Transfusion Medicine and Hematology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano Italy.ORCID https://orcid.org/0000-0003-2225-897X
Marta Clos-SansalvadorREMAR-IGTP Group Germans Trias i Pujol Research Institute (IGTP) & Nephrology Department University Hospital Germans Trias i Pujol (HUGTiP) Badalona (Barcelona) Catalonia Spain.
André Cronemberger AndradeExperimental and Clinical Cell Therapy Institute (ExCT) Spinal Cord Injury and Tissue Regeneration Center Paracelsus Medical University Salzburg Austria.
Tom A P DriedonksCDL Research University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
Sara GiancaterinoDepartment of Civil Chemical Environmental and Materials Engineering Alma Mater Studiorum University of Bologna Bologna Italy.
Stephanie M KronstadtFischell Department of Bioengineering University of Maryland College Park Maryland USA.
Rachel R MizenkoDepartment of Biomedical Engineering University of California Davis California USA.
Muhammad NawazDepartment of Rheumatology and Inflammation Research Institute of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
Xabier OsteikoetxeaHCEMM-SU Extracellular Vesicles Research Group Budapest Hungary.
Carla PereiraExogenus Therapeutics S.A. Cantanhede Portugal.
Surya ShrivastavaCenter for Gene Therapy City of Hope Beckman Research Institute and Hematological Malignancy and Stem Cell Transplantation Institute at the City of Hope Duarte California USA.
Anders Toftegaard BoysenDepartment of Clinical Medicine Aarhus University Aarhus Denmark.ORCID https://orcid.org/0000-0002-0192-1413
Simonides Immanuel van de WakkerDepartment of Cardiology Experimental Cardiology Laboratory University Medical Center Utrecht Utrecht University Utrecht The Netherlands.
Martijn J C van HerwijnenDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht Netherlands.
Xiaoqin WangDiscovery Biology Discovery Sciences BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden.
Dionysios C WatsonUniversity Hospitals Cleveland Medical Center Cleveland Ohio USA.
Mario GimonaGMP Unit Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI-TReCS) Paracelsus Medical University Salzburg Austria.
Maria Kaparakis-LiaskosDepartment of Microbiology, Anatomy, Physiology and Pharmacology La Trobe University Melbourne Victoria Australia.
Konstantin KonstantinovCodiak BioSciences Cambridge Massachusetts USA.
Sai Kiang LimExosome and Secreted Nano-vesicle Institute of Molecular & Cell Biology Singapore Singapore.
Nicole Meisner-KoberDepartment of Biosciences and Medical Biology Paris-Lodron University Salzburg Hellbrunnerstrasse 34 Salzburg Austria.
Michiel StorkIntravacc Bilthoven The Netherlands.
Peter NejsumDepartment of Clinical Medicine Aarhus University Aarhus Denmark.
Annalisa RadeghieriDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.ORCID https://orcid.org/0000-0003-2737-1090
Eva RohdeGMP Unit Spinal Cord Injury & Tissue Regeneration Centre Salzburg (SCI-TReCS) Paracelsus Medical University Salzburg Austria.
Nicolas TouzetCentre for Environmental Research Innovation and Sustainability Institute of Technology Sligo Sligo Ireland.
Marca H M WaubenDepartment of Biomolecular Health Sciences Faculty of Veterinary Medicine Utrecht University Utrecht Netherlands.ORCID https://orcid.org/0000-0003-0360-0311
Kenneth W WitwerDepartment of Molecular and Comparative Pathology Johns Hopkins School of Medicine Baltimore Maryland USA.
Antonella BongiovanniCell-Tech HUB and Institute for Research and Biomedical Innovation National Research Council of Italy (CNR) Palermo Italy.
Paolo BergeseDepartment of Molecular and Translational Medicine University of Brescia Brescia Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) large-scale production is a crucial point for the translation of EVs from discovery to application of EV-based products. In October 2021, the International Society for Extracellular Vesicles (ISEV), along with support by the FET-OPEN projects, "The Extracellular Vesicle Foundry" (evFOUNDRY) and "Extracellular vesicles from a natural source for tailor-made nanomaterials" (VES4US), organized a workshop entitled "massivEVs" to discuss the potential challenges for translation of EV-based products. This report gives an overview of the topics discussed during "massivEVs", the most important points raised, and the points of consensus reached after discussion among academia and industry representatives. Overall, the review of the existing EV manufacturing, upscaling challenges and directions for their resolution highlighted in the workshop painted an optimistic future for the expanding EV field.

Indexed as

EV‐based productsextracellular vesiclesISEV workshoplarge‐scale productionmanufacturingprocessingregulatory issues

Identifiers

PMID38939213
PMCPMC11080784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.